PG128 IMPACT OF CERTOLIZUMAB PEGOL ON QUALITY-ADJUSTED LIFE-YEARS IN TWO INDUCTION AND MAINTENANCE TRIALS IN PATIENTS WITH ACTIVE CROHN'S DISEASE
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65277-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)65277-1/fulltext
Title :
PG128 IMPACT OF CERTOLIZUMAB PEGOL ON QUALITY-ADJUSTED LIFE-YEARS IN TWO INDUCTION AND MAINTENANCE TRIALS IN PATIENTS WITH ACTIVE CROHN'S DISEASE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65277-1&doi=10.1016/S1098-3015(10)65277-1
First page :
Section Title :
Open access? :
No
Section Order :
436